Back to Stakeholders
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchUniversities and Colleges with Dedicated Psychedelic Research Groups
Media, Education & EngagementEducational Platforms & ResourcesOnline Resources
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & Manufacturing
Media, Education & EngagementEducational Platforms & Resources
Media, Education & Engagement

New York University

United States
2 Trials1 Paper

The Center for Psychedelic Medicine at NYU Langone Health is directed by Dr. Michael Bogenschutz and performs health-focused research across the translational spectrum, from basic science to large-phase clinical trials. The center has three transdisciplinary areas of focus: psychiatry, medicine, and preclinical research. Currently, the team is actively investigating clinical applications for various psychedelic compounds, leading robust studies on psilocybin-assisted therapy for alcohol use disorder, major depression, and advanced cancer-related psychiatric distress.

Course Provider

1 active

Active Courses

1

Upcoming Cohorts

0

Evergreen

1

Price Range

Varies

Course Status

Showing 1of 1linked courses for New York University.

Business & Practice

1

Research & Science

1

Academic Research

1 papers

Published Papers

1

Trial Involvement

2

Distinct Focus Topics

0

Latest Publication

Feb 5, 2026

Quick Facts

Type
academic
HQ
United States
Website
Visit

Collaborated Trials

2
Not yet recruitingI

Ketamine Biomarker Validation

Start Date
Compounds
Ketamine
RecruitingII

5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder

Start Date
Compounds
Psilocybin, Placebo

Research Papers

1
Open Accessindividual

Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions

In a randomised, parallel-group waitlist-controlled exploratory study (n=29) of psychedelic-naïve clergy, two supported psilocybin sessions were well tolerated and produced significant, sustained increases in religious practices, attitudes, perceived leadership effectiveness, and broader psychological wellbeing. These effects persisted up to 16 months and were frequently rated among participants' most spiritually meaningful experiences.

Published
Journal
Psychedelic Medicine
Authors
Griffiths, R. R., Jesse, R., Richards, W. A., Johnson, M. W., Sepeda, N. D., Bossis, A. P., Ross, S.